drugset / Trial / NCT00170755
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety, tolerability and efficacy of darifenacin, in the long-term treatment of adult patients with overactive bladder.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | 7.5 mg | Oral |
| Subject | Darifenacin | Small molecule | 15 mg | Oral |